Ticagrelor Medication Information
Learn everything you need to know about Ticagrelor-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.
Get up-to-date information on side effects, precautions, warnings, and proper storage to ensure safe usage.
Explore Ticagrelor brand names commonly used in India and internationally, along with detailed pricing information. Consult your healthcare provider for tailored medical advice.
Generic Name : Ticagrelor Pronunciation : tye-KA-grel-or ICD Code : Y44.2 Therapeutic Classification : Anticoagulants / AntithromboticsBrand Names or Trade Names of Ticagrelor
International :
Brilinta
Why is Ticagrelor Prescribed? (Indications)
This medication is a platelet aggregation inhibitor, prescribed for reducing death rate in patients with myocardial infarction and angina pectoris. It works by preventing platelets from collecting and forming clots.When should Ticagrelor not be taken? (Contraindications)
Contraindicated in patients with severe liver problems, active bleeding, stroke, and hypersensitivity.What is the dosage of Ticagrelor?
Adult- PO- The recommended initial dose is 180 mg (two 90 mg tablets) and continue treatment with 90 mg twice daily.How should Ticagrelor be taken?
It comes as a tablet to take by mouth with or without food.What are the warnings and precautions for Ticagrelor?
• Caution should be exercised in patients with history of lung, liver or kidney disease, stomach or bowel bleeding, recent injury, irregular heartbeat, stroke, gout, who are taking other medications, any allergy, elderly, children, during pregnancy and breastfeeding.• It may cause dizziness, do not drive a car or operate machinery while taking this medication.
• It may reduce platelet counts; avoid injury or bruising.